Data help define relationship between HPV, bladder cancer
“HPV6 positive serology was associated with an increased odds of bladder cancer, and I saw a trend in that it was younger patients with bladder cancer who had the HPV6 positivity,” says Lael S. Reinstatler, MD, MPH, in this video interview.
While previous research has shown a potential relationship between human papillomavirus (HPV) and bladder cancer, a recently reported study has more clearly defined this association.
At the Genitourinary Cancers Symposium in San Francisco, the authors of a study using a large, nationally representative database reported a significant association of HPV6 positive serology with a diagnosis of bladder cancer.
“HPV6 positive serology was associated with an increased odds of bladder cancer, and I saw a trend in that it was younger patients with bladder cancer who had the HPV6 positivity,” said first author Lael S. Reinstatler, MD, MPH, of Dartmouth Hitchcock Medical Center Lebanon, NH.
In this Urology Times video, Dr. Reinstatler describes the study’s unique methodology, other key findings, and the next steps in her group’s research.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.
